Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

14%

1 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 2

4(57.1%)

N/A

2(28.6%)

Phase 3

1(14.3%)

7Total

Phase 2(4)

N/A(2)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT07213089Phase 2Completed

Immunogenicity of a Combined Diphtheria-Tetanus-recombinant Acellular Pertussis (DTaP) Vaccine in Healthy Toddlers

Role: collaborator

NCT02961426Phase 2Unknown

Strategic Transformation of the Market of HCV Treatments

Role: collaborator

NCT01312545Not ApplicableCompleted

Comparison of Local Made and Imported Porous Polyethylene Orbital Implant for Enucleation in Thailand

Role: collaborator

NCT03173820Not ApplicableUnknown

Clinical Trial in Assigning of Tacrolimus Dosage Regimen According to CYP3A5 Genotype in Kidney Transplant Recipients

Role: collaborator

NCT00826163Phase 3Completed

Innate Immune Responses in Chronic Obstructive Pulmonary Disease (COPD) Patients

Role: collaborator

NCT01553708Phase 2Completed

Effect of EGF With Silver Sulfadiazine Cream Compared With Silver Zinc Sulfadiazine Cream for Treatment of Burn Wound

Role: collaborator

NCT01039181Phase 2Unknown

Calcitriol in Advanced Intrahepatic Cholangiocarcinoma

Role: lead

All 7 trials loaded